Brand names and generic drugs, 1974 : hearing before the Subcommittee on Health of the Committee on Labor and Public Welfare, United States Senate, Ninety-third Congress, second session on examination of the Office of Technology Assessment report of the Drug Bioequivalence Study Panel, July 22, 1974.

Similar Items

• Brand names and generic drugs, 1974 : hearing before the Subcommittee on Health of the Committee on Labor and Public Welfare, United States Senate, Ninety-third Congress, second session, on examination of the Office of Technology Assessment report of the Drug Bioequivalence Study Panel, July 22, 1974
  Published: (1974)
• Paying off generics to prevent competition with brand name drugs : should it be prohibited? : hearing before the Committee on the Judiciary, United States Senate, One Hundred Tenth Congress, first session, January 17, 2007.
  Published: (2007)
• Paying off generics to prevent competition with brand name drugs : should it be prohibited? : hearing before the Committee on the Judiciary, United States Senate, One Hundred Tenth Congress, first session, January 17, 2007
  Published: (2007)
• FDA's generic drug enforcement and approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, March 7 and June 5, 1991.
  Published: (1992)
• Rx for generic drug safety : accurate information for older Americans : hearing before the Subcommittee on Housing and Consumer Interests of the Select Committee on Aging, House of Representatives, One Hundred First Congress, second session, March 1, 1990
  Published: (1990)